Alpha Tau Medical Ltd. Warrant (DRTSW)
NASDAQ
4.18
-0.36 (-7.82%)
Closed
Sep 18, 2026
Day's Range
4.184.35
52 wk Range
0.27254.59
Financial Statements - DRTSW - Alpha Tau Medical Ltd. Warrant
Revenue
0
Net Income
-42.62M▼ 34.3%
EBITDA
-37.29M▼ 21.5%
Free Cash Flow
-32.75M▼ 48.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -42.28M | -36.04M | -35.68M | -32.13M | -13.79M | -9.24M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -3.63M | 365K | 1.82M | -3.37M | -13.66M | -102K |
| Pre Tax Income | -42.50M | -31.74M | -29.14M | -33.74M | -27.26M | -8.72M |
| Income Tax | 121K | 6K | 16K | 20K | 7K | 158K |
| Net Income | -42.62M | -31.75M | -29.15M | -33.76M | -27.27M | -8.88M |
| EPS Basic | - | - | - | - | - | - |
| EPS Diluted | - | - | - | - | - | - |
| Basic Shares Outstanding | - | - | - | - | - | - |
| Diluted Shares Outstanding | - | - | - | - | - | - |
| Ebit | -42.15M | -31.44M | -29.06M | -33.74M | -27.26M | -9.24M |
| Ebitda | -37.29M | -30.70M | -29.81M | -29.38M | -12.81M | -9.05M |
| Net Income Continuous Operations | -42.62M | -31.75M | -29.15M | -33.76M | -27.27M | -8.88M |
| Minority Interests | - | - | - | - | 0 | 0 |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
